- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 209/48 - Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
Patent holdings for IPC class C07D 209/48
Total number of patents in this class: 757
10-year publication summary
|
51
|
77
|
66
|
69
|
61
|
50
|
50
|
39
|
33
|
9
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17205 |
18 |
| Amgen Inc. | 3779 |
12 |
| Cancer Research Technology Limited | 542 |
12 |
| FUJIFILM Corporation | 27102 |
10 |
| Ranbaxy Laboratories Limited | 453 |
10 |
| Celgene Corporation | 1412 |
8 |
| The Scripps Research Institute | 1364 |
8 |
| SHPP Global Technologies B.V. | 1045 |
8 |
| Massachusetts Institute of Technology | 9795 |
7 |
| ExxonMobil Chemical Patents Inc. | 4286 |
7 |
| Boehringer Ingelheim International GmbH | 4629 |
6 |
| Syngenta Participations AG | 4970 |
6 |
| Wisconsin Alumni Research Foundation | 3774 |
6 |
| SABIC Global Technologies B.V. | 4044 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
6 |
| Vectus Biosystems Limited | 36 |
6 |
| Zeon Corporation | 3854 |
6 |
| Siemens Medical Solutions USA, Inc. | 1584 |
5 |
| Astex Therapeutics Limited | 267 |
5 |
| The Broad Institute, Inc. | 1584 |
5 |
| Other owners | 600 |